🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST

AmCad BioMed Revenue

AmCad BioMed had revenue of 7.99M TWD in the quarter ending September 30, 2026, a decrease of -23.40%. This brings the company's total for the last twelve months to 26.16M, down -39.87% year-over-year. In the year 2025, AmCad BioMed had annual revenue of 30.44M, down -42.69%. That makes AmCad BioMed the 43,989th largest company in the world by revenue and 2,164th in Taiwan.

Revenue (ttm)
26.16M
Revenue Growth
-39.87%
P/S Ratio
26.75
Revenue / Employee
769.47K
Employees
34
Market Cap
699.83M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Precise Medical Devices 21.31M 70.0%
  • Medical Diagnostic Software 9.13M 30.0%

By Geography

Chart
  • Taiwan 12.48M 41.0%
  • Europe 8.76M 28.8%
  • Asia (excluding Taiwan, and China) 7.52M 24.7%
  • China 1.29M 4.2%
  • Overseas 384.00K 1.3%
Fiscal year ended Dec 31, 2025 See the full AmCad BioMed breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.44M-22.67M-42.69%
Dec 31, 202453.11M-12.15M-18.62%
Dec 31, 202365.26M3.63M5.88%
Dec 31, 202261.63M-24.16M-28.16%
Dec 31, 202185.79M21.85M34.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.